NCT06408181View on ClinicalTrials.gov

APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia

PHASE3RecruitingINTERVENTIONAL
Enrollment

1,150

Participants

Timeline

Start Date

June 12, 2024

Primary Completion Date

June 30, 2029

Study Completion Date

June 30, 2029

Conditions
Pre-EclampsiaPregnancy Loss
Interventions
DRUG

Aspirin 162 mg

Aspirin is a nonsteroidal anti-inflammatory drug.

DRUG

Aspirin 81mg

Aspirin is a nonsteroidal anti-inflammatory drug.

Trial Locations (1)

19104

RECRUITING

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

University of Pennsylvania

OTHER